drugset / Trial / NCT02183129

Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the Knee

NCT02183129

Phase 4 Completed 91 enrolled Boehringer Ingelheim
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess the efficacy and safety of meloxicam 7.5mg once daily compared with diclofenac 100mg SR once daily over a treatment period of 8 weeks

Timeline

Start
1999-04-01
Primary completion
1999-11-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified 100 mg
Subject Meloxicam Small molecule 7.5 mg

Indications